Arrowhead Pharmaceuticals (ARWR) Asset Utilization Ratio (2011 - 2026)
Arrowhead Pharmaceuticals' (ARWR) Asset Utilization Ratio stood at 0.31 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 21.2% from 0.39 a year earlier and down 4.8% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Asset Utilization Ratio came in at 0.66.
- Across earlier fiscal years, Asset Utilization Ratio came in at 0.00 in FY2024 (-98.9%), 0.33 in FY2023 (-4.8%), 0.35 in FY2022 (+54.6%) and 0.22 in FY2021 (+11.2%).
- The fiscal Q3 2026 figure is the lowest quarterly Asset Utilization Ratio since fiscal Q1 2025.
- On a year-over-year basis, Asset Utilization Ratio rose in 1 of the last five quarters, with growth averaging 119.3%.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 839.5% in fiscal Q2 2025, against a decline of 99.1% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 0.32 (Q2 2026), 0.73 (Q1 2026) and 0.60 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 0.47 |
| 10 | Arrowhead Pharmaceuticals | 9.35 Bn | 4.13 Bn | - | 0.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.31 |
| Mar 31, 2026 | 0.32 |
| Dec 31, 2025 | 0.73 |
| Sep 30, 2025 | 0.60 |
| Jun 30, 2025 | 0.39 |
| Mar 31, 2025 | 0.42 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.26 |
| Sep 30, 2023 | 0.31 |
| Jun 30, 2023 | 0.30 |
| Mar 31, 2023 | 0.31 |
| Dec 31, 2022 | 0.35 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.39 |
| Dec 31, 2021 | 0.21 |
| Sep 30, 2021 | 0.19 |
API Access
Arrowhead Pharmaceuticals Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();